Dipeptidyl Peptidase IV Inhibitory Activity of Berberine and Mangiferin: An In Silico Approach

<p><strong>Background:</strong> Dipeptidyl peptidase-IV (DDP-IV) Inhibitors may represent single anti-diabetic drugs, the multiple actions of which may translate into demonstrable therapeutic benefits in   diabetes. The marketed synthetic DPP-IV Inhibitors are expensive drugs and h...

Full description

Saved in:
Bibliographic Details
Main Authors: Ipseeta Ray Mohanty (Author), Selvaa Kumar (Author), Rajesh Suman (Author)
Format: Book
Published: International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications, 2017-07-08.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items